RapidAI is the leader in using AI to combat vascular and neurovascular conditions. Based on intellig
Location: United States, California, San Mateo
Employees: 51-200
Total raised: $100M
Founded date: 2012
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.07.2023 | Series C | $75M | - |
| 17.09.2020 | Series B | $25M | - |
Mentions in press and media 19
| Date | Title | Description |
| 06.05.2024 | RapidAI Scores FDA Clearance, Bringing AI-Powered Stroke Assessment to the Interventional Suite | - |
| 27.11.2023 | New Rapid Edge Cloud Platform, AI CT Suite and Japanese Expansion by RapidAI | Attendees at RSNA 2023 will be among the first to learn about the digital health leader’s latest clinical advancements and international expansion Related Posts Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates Nov ... |
| 10.11.2023 | RapidAI Receives FDA Clearance for Rapid SDH (Subdural Hematoma) for Trauma Care | What You Should Know: – RapidAI has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric acute and chronic subdural hematoma. – The need for the RapidAI solution is urgent, ... |
| 25.10.2023 | Missouri Hospital Taps RapidAI to Enhance Rural Stroke Care | What You Should Know: – Texas County Memorial Hospital, a hospital in rural Missouri has selected RapidAI to deploy its core stroke imaging and workflow products. – As a Level III stroke center, TCMH’s closest Level I facility is over 90 mi... |
| 28.07.2023 | RapidAI Announces $75 Million Growth Investment Led by Vista Credit Partners | Funding intended to fuel continued innovation of RapidAI’s advanced clinical decision and workflow support technology; further establish a leadership position in clinical AI solutions RapidAI, a global leader in developing Artificial Intell... |
| 27.07.2023 | RapidAI Raises $75M in Series C Funding | RapidAI, a San Mateo, CA-based developer of Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, raised $75m in Series C funding. The round was led by Vista ... |
| 27.07.2023 | RapidAI Lands $75M Series C Round | SAN MATEO, CA, RapidAI today announced $75 million in Series C funding round. >> Click here for more funding data on RapidAI >> To export RapidAI funding data to PDF and Excel, click here RapidAI, a global leader in devel... |
| 27.07.2023 | RapidAI Raises $75M To Help Diagnose Strokes | 5 Shares Email Facebook Twitter LinkedIn Every industry will be impacted by the rise of artificial intelligence, and that certainly will include health care in a big way. RapidAI became the latest startup to raise a significant amount of mo... |
| 27.07.2023 | RapidAI Secures $75M for AI-Driven Stroke Care Solutions | What You Should Know: – RapidAI, a San Mateo, CA-based digital health company developing artificial intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, today announced... |
| 19.04.2023 | RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage | Part of RapidAI’s industry-leading stroke solution, Rapid NCCT Stroke supports faster treatment and transfer decisions while driving greater equity of care RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decisi... |
Show more